|By Business Wire||
|July 29, 2014 04:03 PM EDT||
Castlight Health®, Inc. (NYSE:CSLT), a pioneer of the Enterprise Healthcare Cloud, today announced results for its second quarter ended June 30, 2014.
“Demand for Castlight’s Enterprise Healthcare Cloud remains strong as large organizations are increasingly evaluating enterprise healthcare technology to gain control of their healthcare spending,” said Giovanni Colella, M.D., co-founder and Chief Executive Officer of Castlight Health. “We ended the second quarter with 130 customers and expanded our Fortune 500 customer list by more than 20 percent. New large customers included Google, Kellogg Company, Texas Instruments and Sprint Corporation, among others. Further, we continue to execute well. We launched 13 additional customers during the second quarter, including CalPERS, and implemented Castlight Pharmacy and Castlight Rewards for 12 existing customers.”
Colella continued, “We continue to launch new products and lead the way with technologies that enable innovative benefit designs for our customers. We were pleased to announce the upcoming launch of Castlight Dental, which is the newest significant expansion of our Castlight Care Solution Center alongside Castlight Medical and Castlight Pharmacy.”
Financial Performance for the Three Months Ended June 30, 2014
- Total revenue for the second quarter of 2014 was $10.5 million, an increase of 353% from the second quarter of 2013. Subscription revenue was $9.6 million, an increase of 359% on a year-over-year basis. Professional services revenue was $1.0 million, an increase of 304% compared with the same period last year.
- Gross margin for the second quarter of 2014 was 29.6%, compared to a gross loss of 64.9% in the second quarter of 2013. Non-GAAP gross margin for the second quarter of 2014 was 32.6% compared to a gross loss of 63.9% in the second quarter of 2013.
- Operating loss for the second quarter of 2014 was $21.8 million, compared to an operating loss of $14.2 million during the second quarter of 2013. Non-GAAP operating loss for the second quarter of 2014 was $18.8 million, compared to a non-GAAP operating loss of $13.7 million during the second quarter of 2013.
- Net loss per basic and diluted share was ($0.24) in the second quarter of 2014, compared to a loss of ($1.47) per share in the second quarter of 2013. The non-GAAP net loss per share for the second quarter of 2014 was ($0.21), compared to a loss of ($1.43) per share in the second quarter of 2013. For both GAAP and non-GAAP purposes, the weighted average basic and diluted share count for the second quarter of 2014 was 89.5 million compared to 9.6 million in the second quarter of 2013.
- Total cash, cash equivalents and marketable securities were $217.9 million at the end of the second quarter of 2014, compared to $239.7 million at the end of last quarter. Cash used in operations for the second quarter of 2014 was $19.6 million, compared to $16.1 million used in operations last quarter.
A reconciliation of GAAP to non-GAAP results has been provided in this press release in the accompanying tables. An explanation of these measures is also included below under the heading “Non-GAAP Financial Measures”.
Q3 2014 Guidance: Revenue for the company’s third fiscal quarter is expected to be in the range of $11.3 million to $11.6 million, an increase of 214% to 222% year-over-year. Non-GAAP operating loss is expected to be in the range of ($18.7) million to ($19.0) million. Non-GAAP basic and diluted loss per share is expected to be approximately ($0.21) based on 90.0 million weighted average basic and diluted common shares outstanding.
Full Year 2014 Guidance: Revenue for the company’s full year 2014 is expected to be in the range of $42.6 million to $43.2 million, an increase of 228% to 232% year-over- year. Non-GAAP operating loss is expected to be in the range of ($75.0) million to ($76.0) million. Non-GAAP basic and diluted loss per share is expected to be in the range of ($1.00) to ($1.01) based on 75.0 million weighted average basic and diluted common shares outstanding.
For both the third quarter and the full year 2014, non-GAAP estimates exclude the effects of stock-based compensation expense and warrant expense.
Castlight Health announced today that Randy Womack, chief operating officer, will step down September 30, 2014 after nearly four years of service with the company. Mr. Womack’s responsibilities will be assumed by other members of Castlight’s management team after a seamless transition process is completed.
Additionally, Concur CEO Steve Singh has joined Castlight’s Board of Directors, effective immediately. Concurrently, directors Bob Kocher, M.D., partner at Venrock, and Christopher P. Michel, managing director at Nautilus Ventures, departed the Board. Dr. Kocher will remain as an advisor to the company, and Bryan Roberts, co-founder of Castlight and general partner at Venrock, remains Castlight’s Chairman of the Board. These changes follow the April addition of Ed Park, executive vice president and chief operating officer of athenahealth to the Board of Directors.
“We would like to thank Randy for his efforts to help make Castlight such a great company and achieve such strong momentum as a business. Randy has decided to leave the company with the success of his third IPO to pursue his passion for startups. We wish him every success in his future endeavors,” said Colella. “Moving forward, Castlight has an incredibly strong group of experienced, proven leaders. I look forward to working with them to continue to capture growth and realize innovation opportunities.”
Quarterly Conference Call
Castlight Health will host a conference call to discuss its second quarter results today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live audio webcast of the conference call, together with detailed financial information, can be accessed through the company's Investor Relations website at http://ir.castlighthealth.com. In addition, an archive of the audiocast can be accessed through the same link. Participants who choose to call in to the conference call can do so by dialing 1-201-689-8562. A replay will be available at 1-858-384-5517, passcode 13586458, until midnight (Eastern Time) August 5, 2014.
About Castlight Health
Castlight Health, Inc. (NYSE: CSLT) believes great healthcare builds great business. The Castlight Enterprise Healthcare Cloud enables employers to deliver cost-effective benefits, provides medical professionals and health plans a merit-based market to showcase their services, and – most importantly – empowers employees to make informed choices with a clear understanding of costs and likely outcomes. For more information visit www.castlighthealth.com. Follow us on Twitter and LinkedIn and Like us on Facebook. Source: Castlight Health.
Non-GAAP Financial Measures
To supplement Castlight Health’s financial statements presented in accordance with generally accepted accounting principles (GAAP), we also use and provide investors and others with non-GAAP measures of certain components of financial performance, including non-GAAP gross margin (loss), non-GAAP operating expense, non-GAAP operating loss and non-GAAP net loss per share. These non-GAAP financial measures differ from GAAP financial measures in that they exclude stock-based compensation, expense for a warrant issued to a third-party service provider and the associated tax impact of these items, where applicable.
We believe that these non-GAAP financial measures provide useful supplemental information to investors and others, facilitate the analysis of the company’s core operating results and comparison of operating results across reporting periods, and can help enhance overall understanding of the company’s historical financial performance.
We have provided a reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure, except that we have not reconciled our non-GAAP operating loss and net loss per share guidance for the third quarter and full fiscal year of 2014 to comparable GAAP operating loss and net loss per share guidance because we do not provide guidance for stock-based compensation expense and warrant expense, which are reconciling items between GAAP and non-GAAP operating loss. The factors that may impact our future stock-based compensation expense and warrant expense are out of our control and/or cannot be reasonably predicted, and therefore we are unable to provide such guidance without unreasonable effort.
These non-GAAP financial measures should be considered in addition to, not as a substitute for or in isolation from, measures prepared in accordance with GAAP. Further, these non-GAAP measures may differ from the non-GAAP information used by other companies, including peer companies, and therefore comparability may be limited. Castlight Health encourages investors and others to review the company’s financial information in its entirety and not rely on a single financial measure.
Safe Harbor For Forward-Looking Statements
This press release contains forward-looking statements about Castlight Health’s expectations, plans, intentions, and strategies, including, but not limited to, statements regarding Castlight Health’s third quarter and full year projections, our expectations for future performance of our business, market growth and business conditions, future innovation by the company and future developments with respect to the digital healthcare industry. Statements including words such as “anticipate,” “believe,” “estimate,” “will,” “continue,” “expect,” or “future,” and statements in the future tense are forward-looking statements. These forward-looking statements involve risks and uncertainties, as well as assumptions, which, if they do not fully materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. The risks and uncertainties include those described in Castlight Health’s documents filed with or furnished to the Securities and Exchange Commission. All forward-looking statements in this press release are based on information available to Castlight Health as of the date hereof. Castlight Health assumes no obligation to update these forward-looking statements.
Copyright 2014 Castlight Health, Inc. Castlight Health, Castlight, Castlight Medical, Castlight Pharmacy, Castlight Dental, Castlight Care Solution Center are trademarks and/or registered trademarks of Castlight Health Inc. in the United States and other countries. Other company and product names may be trademarks of the respective companies with which they are associated.
|CASTLIGHT HEALTH, INC.|
|CONDENSED CONSOLIDATED BALANCE SHEETS|
|June 30,||December 31,|
|Cash and cash equivalents||$||35,268||$||25,154|
|Accounts receivable, net||10,392||5,065|
|Prepaid expenses and other current assets||3,010||1,583|
|Total current assets||176,176||77,467|
|Property and equipment, net||3,164||2,631|
|Marketable securities, noncurrent||58,095||-|
Restricted cash, noncurrent
|Deferred commissions, noncurrent||1,648||1,821|
|Liabilities, convertible preferred stock and stockholders' equity (deficit)|
|Accrued expenses and other current liabilities||3,937||4,998|
|Total current liabilities||27,819||22,523|
|Deferred revenue, noncurrent||5,780||4,548|
|Other liabilities, noncurrent||317||373|
|Commitments and contingencies|
|Convertible preferred stock||-||180,423|
|Stockholders' equity (deficit)||205,547||(124,350||)|
|Total liabilities, convertible preferred stock and stockholders' equity (deficit)||$||239,463||$||83,517|
|CASTLIGHT HEALTH, INC.|
|CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS|
|(In thousands, except per share data)|
|Three Months Ended June 30,||Six Months Ended June 30,|
|Cost of revenue:|
|Cost of subscription (1)||2,915||1,460||5,627||2,664|
|Cost of professional services (1)||4,502||2,373||8,373||4,426|
|Total cost of revenue||7,417||3,833||14,000||7,090|
|Gross profit (loss)||3,116||(1,508||)||4,909||(2,858||)|
|Sales and marketing (1)||14,947||7,108||31,507||12,873|
|Research and development (1)||5,476||3,616||11,003||6,524|
|General and administrative (1)||4,519||1,981||8,529||3,441|
|Total operating expenses||24,942||12,705||51,039||22,838|
|Other income, net||50||40||73||90|
|Net loss per share, basic and diluted||$||(0.24||)||$||(1.47||)||$||(0.86||)||$||(2.71||)|
|Weighted-average shares used in basic and diluted net loss per share||89,520||9,619||53,284||9,438|
|(1)Includes stock-based compensation expense as follows:|
|Three Months Ended June 30,||Six Months Ended June 30,|
|Cost of revenue:|
|Cost of subscription||$||35||$||-||$||39||$||1|
|Cost of professional services||280||23||420||52|
|Sales and marketing||1,152||225||2,326||408|
|Research and development||493||61||914||110|
|General and administrative||980||156||1,794||272|
|CASTLIGHT HEALTH, INC.|
|CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS|
|Three Months Ended June 30,||Six Months Ended June 30,|
|Adjustments to reconcile net loss to net cash used in operating activities:|
|Amortization of deferred commission||868||196||2,244||325|
|Accretion and amortization of marketable securities||373||193||497||421|
|Expense related to issuance of warrant||70||-||2,499||-|
|Changes in operating assets and liabilities:|
|Prepaid expenses and other assets||(596||)||(435||)||(1,677||)||(535||)|
|Accrued expenses and other liabilities||2,173||2,406||(1,203||)||1,109|
|Net cash used in operating activities||(19,574||)||(10,005||)||(35,635||)||(22,159||)|
|Decrease restricted cash, net||101||-||101||-|
|Purchase of property and equipment||(311||)||(408||)||(967||)||(1,118||)|
|Purchase of marketable securities||(126,442||)||(8,382||)||(162,175||)||(16,480||)|
|Sales of marketable securities||-||-||13,000||5,000|
|Maturities of marketable securities||3,000||39,075||8,000||44,075|
|Net cash (used in) provided by investing activities||(123,652||)||30,285||(142,041||)||31,477|
|Proceeds from the exercise of stock options||106||154||1,628||200|
|Payments of deferred financing costs||(1,679||)||-||(3,781||)||-|
Net proceeds from initial public offering
|Net cash (used in) provided by financing activities||(1,573||)||154||187,790||200|
|Net increase (decrease) in cash and cash equivalents||(144,799||)||20,434||10,114||9,518|
|Cash and cash equivalents at beginning of the period||180,067||31,618||25,154||42,534|
|Cash and cash equivalents at end of the period||$||35,268||$||52,052||$||35,268||$||52,052|
|CASTLIGHT HEALTH, INC.|
|RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES|
|(In thousands, except per share data)|
|Three Months Ended||Six Months Ended|
|June 30,||March 31,||June 30,||June 30,||June 30,|
|Gross profit (loss):|
GAAP gross profit subscription
|GAAP gross margin subscription||69.6||%||63.7||%||30.1||%||67.0||%||30.4||%|
|Stock-based compensation expense included in cost of revenue subscription||35||4||-||39||1|
|Non-GAAP gross profit subscription||$||6,696||$||4,755||$||628||$||11,451||$||1,164|
|Non-GAAP gross margin subscription||69.9||%||63.7||%||30.1||%||67.2||%||30.4||%|
|GAAP gross loss professional services||$||(3,545||)||$||(2,958||)||$||(2,136||)||$||(6,503||)||$||(4,021||)|
|GAAP gross loss percentage professional services||(370||)||%||(324||)||%||(901||)||%||(348||)||%||(993||)||%|
|Stock-based compensation expense included in cost of revenue professional services||280||140||23||420||52|
|Non-GAAP gross loss professional services||$||(3,265||)||$||(2,818||)||$||(2,113||)||$||(6,083||)||$||(3,969||)|
|Non-GAAP gross loss percentage professional services||(341||)||%||(309||)||%||(892||)||%||(325||)||%||(980||)||%|
|GAAP gross profit (loss)||$||3,116||$||1,793||$||(1,508||)||$||4,909||$||(2,858||)|
|GAAP gross margin (loss percentage)||29.6||%||21.4||%||(64.9||)||%||26.0||%||(67.5||)||%|
|Impact of non-GAAP adjustments||315||144||23||459||53|
|Non-GAAP gross profit (loss)||$||3,431||$||1,937||$||(1,485||)||$||5,368||$||(2,805||)|
|Non-GAAP gross margin (loss percentage)||32.6||%||23.1||%||(63.9||)||%||28.4||%||(66.3||)||%|
|GAAP sales and marketing||$||14,947||$||16,560||$||7,108||$||31,507||$||12,873|
|Expense related to warrant||(70||)||(2,429||)||-||(2,499||)||-|
|Stock-based compensation expense included in sales and marketing||(1,152||)||(1,174||)||(225||)||(2,326||)||(408||)|
|Non-GAAP sales and marketing||$||13,725||$||12,957||$||6,883||$||26,682||$||12,465|
|GAAP research and development||$||5,476||$||5,527||$||3,616||$||11,003||$||6,524|
|Stock-based compensation expense included in research and development||(493||)||(421||)||(61||)||(914||)||(110||)|
|Non-GAAP research and development||$||4,983||$||5,106||$||3,555||$||10,089||$||6,414|
|GAAP general and administrative||$||4,519||$||4,010||$||1,981||$||8,529||$||3,441|
|Stock-based compensation expense included in general and administrative||(980||)||(814||)||(156||)||(1,794||)||(272||)|
|Non-GAAP general and administrative||$||3,539||$||3,196||$||1,825||$||6,735||$||3,169|
|GAAP operating expenses||$||24,942||$||26,097||$||12,705||$||51,039||$||22,838|
|Impact of non-GAAP adjustments||(2,695||)||(4,838||)||(442||)||(7,533||)||(790||)|
|Non-GAAP operating expenses||$||22,247||$||21,259||$||12,263||$||43,506||$||22,048|
|GAAP operating loss||$||(21,826||)||$||(24,304||)||$||(14,213||)||$||(46,130||)||$||(25,696||)|
|Impact of non-GAAP adjustments||3,010||4,982||465||7,992||843|
|Non-GAAP operating loss||$||(18,816||)||$||(19,322||)||$||(13,748||)||$||(38,138||)||$||(24,853||)|
|Net loss and net loss per share:|
|GAAP net loss||$||(21,776||)||$||(24,281||)||$||(14,173||)||$||(46,057||)||$||(25,606||)|
|Total pre-tax impact of non-GAAP adjustments||3,010||4,982||465||7,992||843|
|Income tax impact of non-GAAP adjustments||-||-||-||-||-|
|Non-GAAP net loss||$||(18,766||)||$||(19,299||)||$||(13,708||)||$||(38,065||)||$||(24,763||)|
|Basic and Diluted net loss per share|
|Shares used in basic and diluted net loss per share computation||89,520||26,970||9,619||53,284||9,438|
|Free Cash Flow|
|GAAP net cash flow used in operating activities||$||(19,574||)||$||(16,061||)||$||(10,005||)||$||(35,635||)||$||(22,159||)|
|Purchase of property and equipment||(311||)||(656||)||(408||)||(967||)||(1,118||)|
|Free cash flow||$||(19,885||)||$||(16,717||)||$||(10,413||)||$||(36,602||)||$||(23,277||)|
Internet of @ThingsExpo, taking place June 6-8, 2017 at the Javits Center in New York City, New York, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. @ThingsExpo New York Call for Papers is now open.
Jan. 24, 2017 06:15 PM EST Reads: 3,824
Fifty billion connected devices and still no winning protocols standards. HTTP, WebSockets, MQTT, and CoAP seem to be leading in the IoT protocol race at the moment but many more protocols are getting introduced on a regular basis. Each protocol has its pros and cons depending on the nature of the communications. Does there really need to be only one protocol to rule them all? Of course not. In his session at @ThingsExpo, Chris Matthieu, co-founder and CTO of Octoblu, walked through how Octob...
Jan. 24, 2017 06:15 PM EST Reads: 3,144
“RackN is a software company and we take how a hybrid infrastructure scenario, which consists of clouds, virtualization, traditional data center technologies - how to make them all work together seamlessly from an operational perspective,” stated Dan Choquette, Founder of RackN, in this SYS-CON.tv interview at @DevOpsSummit at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Jan. 24, 2017 04:30 PM EST Reads: 3,661
SYS-CON Events announced today that Dataloop.IO, an innovator in cloud IT-monitoring whose products help organizations save time and money, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Dataloop.IO is an emerging software company on the cutting edge of major IT-infrastructure trends including cloud computing and microservices. The company, founded in the UK but now based in San Fran...
Jan. 24, 2017 04:15 PM EST Reads: 2,732
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...
Jan. 24, 2017 02:30 PM EST Reads: 5,393
"There's a growing demand from users for things to be faster. When you think about all the transactions or interactions users will have with your product and everything that is between those transactions and interactions - what drives us at Catchpoint Systems is the idea to measure that and to analyze it," explained Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Systems, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York Ci...
Jan. 24, 2017 02:30 PM EST Reads: 5,921
WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web communications world. The 6th WebRTC Summit continues our tradition of delivering the latest and greatest presentations within the world of WebRTC. Topics include voice calling, video chat, P2P file sharing, and use cases that have already leveraged the power and convenience of WebRTC.
Jan. 24, 2017 02:15 PM EST Reads: 3,278
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain. In this power panel at @...
Jan. 24, 2017 01:45 PM EST Reads: 3,021
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
Jan. 24, 2017 01:30 PM EST Reads: 4,499
Discover top technologies and tools all under one roof at April 24–28, 2017, at the Westin San Diego in San Diego, CA. Explore the Mobile Dev + Test and IoT Dev + Test Expo and enjoy all of these unique opportunities: The latest solutions, technologies, and tools in mobile or IoT software development and testing. Meet one-on-one with representatives from some of today's most innovative organizations
Jan. 24, 2017 01:00 PM EST Reads: 1,742
SYS-CON Events announced today that Super Micro Computer, Inc., a global leader in Embedded and IoT solutions, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 7-9, 2017, at the Javits Center in New York City, NY. Supermicro (NASDAQ: SMCI), the leading innovator in high-performance, high-efficiency server technology, is a premier provider of advanced server Building Block Solutions® for Data Center, Cloud Computing, Enterprise IT, Hadoop/Big Data, HPC and E...
Jan. 24, 2017 12:45 PM EST Reads: 5,931
@DevOpsSummit taking place June 6-8, 2017 at Javits Center, New York City, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. @DevOpsSummit at Cloud Expo New York Call for Papers is now open.
Jan. 24, 2017 12:30 PM EST Reads: 3,741
“DevOps is really about the business. The business is under pressure today, competitively in the marketplace to respond to the expectations of the customer. The business is driving IT and the problem is that IT isn't responding fast enough," explained Mark Levy, Senior Product Marketing Manager at Serena Software, in this SYS-CON.tv interview at DevOps Summit, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
Jan. 24, 2017 12:15 PM EST Reads: 11,750
SYS-CON Events announced today that Catchpoint Systems, Inc., a provider of innovative web and infrastructure monitoring solutions, has been named “Silver Sponsor” of SYS-CON's DevOps Summit at 18th Cloud Expo New York, which will take place June 7-9, 2016, at the Javits Center in New York City, NY. Catchpoint is a leading Digital Performance Analytics company that provides unparalleled insight into customer-critical services to help consistently deliver an amazing customer experience. Designed ...
Jan. 24, 2017 12:15 PM EST Reads: 6,536
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smart...
Jan. 24, 2017 12:00 PM EST Reads: 2,878